|
The dipeptidyl peptidase-4 inhibitor alogliptin
improves glycemic control in type 2 diabetic
patients undergoing hemodialysis. Y Fujii,M Abe,T Higuchi,M Mizuno,H Suzuki,S
Matsumoto,M Ito,N Maruyama,K Okada,M
Soma Expert Opin Pharmacother 2013 2;14(3):259-
67
Alogliptin ameliorates postprandial lipemia and
postprandial endothelial dysfunction in non- diabetic
subjects: a preliminary report. Y Noda,T Miyoshi,H Oe,Y Ohno,K Nakamura,N
Toh,K Kohno,H Morita,K Kusano,H Ito Cardiovasc Diabetol 2013 1;12(1):8
Percutaneous coronary intervention versus optimal
medical therapy for prevention of spontaneous
myocardial infarction in subjects with stable
ischemic heart disease. S Bangalore,S Pursnani,S Kumar,PG Bagos Circulation 2013 2;127(7):769-81
Disability-adjusted life years (DALYs) for 291
diseases and injuries in 21 regions, 1990-2010: a
systematic analysis for the Global Burden of
Disease Study 2010. Murray CJ, Vos T, Lozano R Lancet. 2013 Dec 15;380(9859):2197-223. doi:
10.1016/S0140-6736(12)61689-4.
Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk. P Choudhary,J Shin,Y Wang,ML Evans,PJ Hammond,D Kerr,JA Shaw,JC Pickup,SA Amiel Diabetes Care 2011 9;34(9):2023-5
A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years. N Mauras,R Beck,D Xing,K Ruedy,B Buckingham,M Tansey,NH White,SA Weinzimer,W Tamborlane,C Kollman Diabetes Care 2012 2;35(2):204-10
Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes. RA Vigersky,SJ Fonda,M Chellappa,MS Walker,NM Ehrhardt Diabetes Care 2012 1;35(1):32-8
Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative. AL Culver,IS Ockene,R Balasubramanian,BC Olendzki,DM Sepavich,J Wactawski-Wende,JE Manson,Y Qiao,S Liu,PA Merriam,C Rahilly-Tierny,F Thomas,JS Berger,JK Ockene,JD Curb,Y Ma Arch Intern Med 2012 1;172(2):144-52
Early Metabolic Markers of the Development of Dysglycemia and Type 2 Diabetes and Their Physiological Significance. E Ferrannini,A Natali,S Camastra,M Nannipieri,A Mari,KP Adam,MV Milburn,G Kastenmüller,J Adamski,T Tuomi,V Lyssenko,L Groop,WE Gall Diabetes 2012 11;():
|